Inmode Ltd(INMD) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 27 at 7:43 PM ET (Korea 10/28 08:43)
Full metrics table
| Index | - | P/E | 11.02 | EPS (ttm) | 1.23 | Insider Own | 16.37% | Shs Outstand | 57.5M | Perf Week | -3.96% |
| Market Cap | 0.78B | Forward P/E | 9.9 | EPS next Y | 5.84% | Insider Trans | - | Shs Float | 48.1M | Perf Month | -4.4% |
| Enterprise Value | 0.28B | PEG | - | EPS next Q | 0.32 | Inst Own | 52.12% | Short Float | 4.61% | Perf Quarter | -10.36% |
| Income | 0.08B | P/S | 2.09 | EPS this Y | -19.01% | Inst Trans | -4.15% | Short Ratio | 4.61 | Perf Half Y | -4.43% |
| Sales | 0.37B | P/B | 1.24 | EPS next 5Y | -3.28% | ROA | 10.85% | Short Interest | 2.22M | Perf YTD | -7.56% |
| Book/sh | 10.95 | P/C | 1.56 | EPS past 3/5Y | -9.87% 6.62% | ROE | 12.33% | 52W High | -18.54% ($16.67) | Perf Year | -13.23% |
| Cash/sh | 8.71 | P/FCF | 8.84 | Sales past 3/5Y | -6.57% 12.44% | ROIC | 12.23% | 52W Low | 6.76% ($12.72) | Perf 3Y | -29.01% |
| Dividend Est. | - | EV/EBITDA | 4.07 | EPS Y/Y TTM | -50.25% | Gross Margin | 76.52% | Volatility(W/M) | 1.46% 1.25% | Perf 5Y | -83.61% |
| Dividend TTM | - | EV/Sales | 0.76 | Sales Y/Y TTM | -6.71% | Oper. Margin | 18.47% | ATR (14) | 0.19 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 7.28 | EPS Q/Q | -31.6% | Profit Margin | 20.69% | RSI (14) | 25.61 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 8.18 | Sales Q/Q | -0.01% | SMA20 | -3.57% ($14.08) | Beta | 1.98 | Target Price | $16.17 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 2026/11/11 | SMA50 | -6.17% ($14.47) | Rel Volume | 0.94 | Prev Close | $13.72 |
| Employees | 660 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | 1.16% 0.74% | SMA200 | -5.3% ($14.34) | Avg Volume(3M) | 0.48M | Price | $13.58 |
| IPO | 2019/8/8 | Option/Short | Yes/Yes | Trades | 3311 | Volume | 451,589 | Change | -1.02% |
💆 InMode (INMD) is a healthcare company that develops and sells radiofrequency- and laser-based aesthetic medical device platforms. It supplies physicians with equipment that enables non-surgical procedures such as body contouring, skin tightening, and wrinkle reduction. Its business model combines equipment sales with disposable applicators, creating a stable, recurring revenue structure.
Over the past 1 year, on the lower side
19% below its 1-year high.
Traded about as much as usual. That is 94% of its average volume.
Next earnings report: November 11
14 days to go.
INMD makes money exceptionally well
Of every $100 in sales, $18.47 is kept as operating profit.
Tap to view numbers
Growth has stalled
Earnings are expected to grow by -19.0% this year.
Tap to view numbers
Within its industry, it looks cheap
For a company earning $100 a year, you would pay $1,102. Peers typically go for $2,793.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -83.6%. The S&P 500 did +70% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership looks stable
Institutions hold 52.1%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #49 of 142 in the industry
Based on market cap of $781M.
FAQ
What kind of company is INMD?
INMD belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of INMD?
The market cap of INMD is approximately $781M, ranking 2,782 within its sector.
What is the P/E ratio of INMD?
INMD has a P/E ratio of approximately 11.0x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for INMD?
INMD has recorded a 52-week high of $16.67 and a low of $12.72.
